首页 > 最新文献

ACS Applied Nano Materials最新文献

英文 中文
Emergence of infectious diseases and role of advanced nanomaterials in point-of-care diagnostics: a review. 传染病的出现和先进纳米材料在护理点诊断中的作用:综述。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-10-15 DOI: 10.1080/02648725.2022.2127070
Kalaimani Markandan, Yong Wei Tiong, Revathy Sankaran, Sakthinathan Subramanian, Uma Devi Markandan, Vishal Chaudhary, Arshid Numan, Mohammad Khalid, Rashmi Walvekar

Infectious outbreaks are the foremost global public health concern, challenging the current healthcare system, which claims millions of lives annually. The most crucial way to control an infectious outbreak is by early detection through point-of-care (POC) diagnostics. POC diagnostics are highly advantageous owing to the prompt diagnosis, which is economical, simple and highly efficient with remote access capabilities. In particular, utilization of nanomaterials to architect POC devices has enabled highly integrated and portable (compact) devices with enhanced efficiency. As such, this review will detail the factors influencing the emergence of infectious diseases and methods for fast and accurate detection, thus elucidating the underlying factors of these infections. Furthermore, it comprehensively highlights the importance of different nanomaterials in POCs to detect nucleic acid, whole pathogens, proteins and antibody detection systems. Finally, we summarize findings reported on nanomaterials based on advanced POCs such as lab-on-chip, lab-on-disc-devices, point-of-action and hospital-on-chip. To this end, we discuss the challenges, potential solutions, prospects of integrating internet-of-things, artificial intelligence, 5G communications and data clouding to achieve intelligent POCs.

传染病爆发是全球公共卫生的首要问题,对现有的医疗保健系统提出了挑战,每年都有数百万人因此而丧生。控制传染病爆发的最关键方法是通过床旁诊断(POC)进行早期检测。POC 诊断具有诊断迅速、经济、简单、高效、可远程访问等优点。特别是,利用纳米材料来设计 POC 设备可以实现高度集成和便携(紧凑)的设备,并提高效率。因此,本综述将详细介绍影响传染病出现的因素以及快速准确的检测方法,从而阐明这些传染病的潜在因素。此外,它还全面强调了不同纳米材料在 POC 中检测核酸、整个病原体、蛋白质和抗体检测系统的重要性。最后,我们总结了基于先进 POC(如片上实验室、片上实验室设备、行动点和医院芯片)的纳米材料的研究成果。为此,我们讨论了整合物联网、人工智能、5G 通信和数据云以实现智能 POCs 的挑战、潜在解决方案和前景。
{"title":"Emergence of infectious diseases and role of advanced nanomaterials in point-of-care diagnostics: a review.","authors":"Kalaimani Markandan, Yong Wei Tiong, Revathy Sankaran, Sakthinathan Subramanian, Uma Devi Markandan, Vishal Chaudhary, Arshid Numan, Mohammad Khalid, Rashmi Walvekar","doi":"10.1080/02648725.2022.2127070","DOIUrl":"10.1080/02648725.2022.2127070","url":null,"abstract":"<p><p>Infectious outbreaks are the foremost global public health concern, challenging the current healthcare system, which claims millions of lives annually. The most crucial way to control an infectious outbreak is by early detection through point-of-care (POC) diagnostics. POC diagnostics are highly advantageous owing to the prompt diagnosis, which is economical, simple and highly efficient with remote access capabilities. In particular, utilization of nanomaterials to architect POC devices has enabled highly integrated and portable (compact) devices with enhanced efficiency. As such, this review will detail the factors influencing the emergence of infectious diseases and methods for fast and accurate detection, thus elucidating the underlying factors of these infections. Furthermore, it comprehensively highlights the importance of different nanomaterials in POCs to detect nucleic acid, whole pathogens, proteins and antibody detection systems. Finally, we summarize findings reported on nanomaterials based on advanced POCs such as lab-on-chip, lab-on-disc-devices, point-of-action and hospital-on-chip. To this end, we discuss the challenges, potential solutions, prospects of integrating internet-of-things, artificial intelligence, 5G communications and data clouding to achieve intelligent POCs.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3438-3526"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33514978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability. 人类羧基酯酶 1 的单核苷酸多态性对底物生物利用率的主要影响。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-08-10 DOI: 10.1080/02648725.2022.2108997
Goutham Yerrakula, Shyno Abraham, Shiji John, Mehrukh Zeharvi, Samuel Gideon George, V Senthil, Fathi Maiz, Md Habibur Rahman

The number of studies and reviews conducted for the Carboxylesterase gene is limited in comparison with other enzymes. Carboxylesterase (CES) gene or human carboxylesterases (hCES) is a multigene protein belonging to the α/β-hydrolase family. Over the last decade, two major carboxylesterases (CES1 and CES2), located at 16q13-q22.1 on human chromosome 16 have been extensively studied as important mediators in the metabolism of a wide range of substrates. hCES1 is the most widely expressed enzyme in humans, and it is found in the liver. In this review, details regarding CES1 substrates include both inducers (e.g. Rifampicin) and inhibitors (e.g. Enalapril, Diltiazem, Simvastatin) and different types of hCES1 polymorphisms (nsSNPs) such as rs2244613 and rs71647871. along with their effects on various CES1 substrates were documented. Few instances where the presence of nsSNPs exerted a positive influence on certain substrates which are hydrolyzed via hCES1, such as anti-platelets like Clopidogrel when co-administered with other medications such as angiotensin-converting enzyme (ACE) inhibitors were also recorded. Remdesivir, an ester prodrug is widely used for the treatment of COVID-19, being a CES substrate, it is a potent inhibitor of CES2 and is hydrolyzed via CES1. The details provided in this review could give a clear-cut idea or information that could be used for further studies regarding the safety and efficacy of CES1 substrate.

与其他酶相比,有关羧基酯酶基因的研究和综述数量有限。羧基酯酶(CES)基因或人类羧基酯酶(hCES)是一种多基因蛋白,属于α/β-水解酶家族。在过去十年中,位于人类第 16 号染色体 16q13-q22.1 位置的两种主要羧基酯酶(CES1 和 CES2)作为多种底物代谢的重要介质受到了广泛研究。在这篇综述中,有关 CES1 底物的详细信息包括诱导剂(如利福平)和抑制剂(如依那普利、地尔硫卓、辛伐他汀)以及不同类型的 hCES1 多态性(nsSNPs),如 rs2244613 和 rs71647871,以及它们对各种 CES1 底物的影响。此外,还记录了一些 nsSNPs 的存在对某些通过 hCES1 进行水解的底物产生积极影响的实例,如氯吡格雷等抗血小板药物与血管紧张素转换酶(ACE)抑制剂等其他药物合用时。雷米地韦是一种酯类原药,被广泛用于治疗 COVID-19,作为一种 CES 底物,它是 CES2 的强效抑制剂,并通过 CES1 进行水解。本综述提供的详细信息可为进一步研究 CES1 底物的安全性和有效性提供清晰的思路或信息。
{"title":"Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability.","authors":"Goutham Yerrakula, Shyno Abraham, Shiji John, Mehrukh Zeharvi, Samuel Gideon George, V Senthil, Fathi Maiz, Md Habibur Rahman","doi":"10.1080/02648725.2022.2108997","DOIUrl":"10.1080/02648725.2022.2108997","url":null,"abstract":"<p><p>The number of studies and reviews conducted for the Carboxylesterase gene is limited in comparison with other enzymes. Carboxylesterase (CES) gene or human carboxylesterases (hCES) is a multigene protein belonging to the α/β-hydrolase family. Over the last decade, two major carboxylesterases (CES1 and CES2), located at 16q13-q22.1 on human chromosome 16 have been extensively studied as important mediators in the metabolism of a wide range of substrates. hCES1 is the most widely expressed enzyme in humans, and it is found in the liver. In this review, details regarding CES1 substrates include both inducers (e.g. Rifampicin) and inhibitors (e.g. Enalapril, Diltiazem, Simvastatin) and different types of hCES1 polymorphisms (nsSNPs) such as rs2244613 and rs71647871. along with their effects on various CES1 substrates were documented. Few instances where the presence of nsSNPs exerted a positive influence on certain substrates which are hydrolyzed via hCES1, such as anti-platelets like Clopidogrel when co-administered with other medications such as angiotensin-converting enzyme (ACE) inhibitors were also recorded. Remdesivir, an ester prodrug is widely used for the treatment of COVID-19, being a CES substrate, it is a potent inhibitor of CES2 and is hydrolyzed via CES1. The details provided in this review could give a clear-cut idea or information that could be used for further studies regarding the safety and efficacy of CES1 substrate.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3174-3192"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40599000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineering core-shell mesoporous silica and Fe3O4@Au nanosystems for targeted cancer therapeutics: a review. 用于癌症靶向治疗的核壳介孔二氧化硅和 Fe3O4@Au 纳米系统工程:综述。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-11-28 DOI: 10.1080/02648725.2022.2147685
Himani Pathania, Priyanka Chauhan, Vishal Chaudhary, Ajit Khosla, Neetika, Sunil Kumar, Gaurav, Mamta Sharma

The extensive utilization of nanoparticles in cancer therapies has inspired a new field of study called cancer nanomedicine. In contrast to traditional anticancer medications, nanomedicines offer a targeted strategy that eliminates side effects and has high efficacy. With its vast surface area, variable pore size, high pore volume, abundant surface chemistry and specific binding affinity, mesoporous silica nanoparticles (MPSNPs) are a potential candidate for cancer diagnosis and treatment. However, there are several bottlenecks associated with nanoparticles, including specific toxicity or affinity towards particular body fluid, which can cater by architecting core-shell nanosystems. The core-shell chemistries, synergistic effects, and interfacial heterojunctions in core-shell nanosystems enhance their stability, catalytic and physicochemical attributes, which possess high performance in cancer therapeutics. This review article summarizes research and development dedicated to engineering mesoporous core-shell nanosystems, especially silica nanoparticles and Fe3O4@Au nanoparticles, owing to their unique physicochemical characteristics. Moreover, it highlights state-of-the-art magnetic and optical attributes of Fe3O4@Au and MPSNP-based cancer therapy strategies. It details the designing of Fe3O4@Au and MPSN to bind with drugs, receptors, ligands, and destroy tumour cells and targeted drug delivery. This review serves as a fundamental comprehensive structure to guide future research towards prospects of core-shell nanosystems based on Fe3O4@Au and MPSNP for cancer theranostics.

纳米粒子在癌症疗法中的广泛应用激发了一个新的研究领域--癌症纳米医学。与传统的抗癌药物相比,纳米药物提供了一种消除副作用且疗效显著的靶向策略。介孔二氧化硅纳米粒子(MPSNPs)具有巨大的表面积、可变的孔径、高孔容积、丰富的表面化学成分和特异的结合亲和力,是癌症诊断和治疗的潜在候选材料。然而,纳米粒子也存在一些瓶颈,包括特定毒性或对特定体液的亲和性,这可以通过构建核壳纳米系统来解决。核壳纳米系统中的核壳化学成分、协同效应和界面异质结增强了其稳定性、催化性和理化属性,在癌症治疗中具有很高的性能。这篇综述文章总结了介孔核壳纳米系统,特别是二氧化硅纳米颗粒和 Fe3O4@Au 纳米颗粒,因其独特的物理化学特性而致力于工程化的研究和开发。此外,报告还重点介绍了基于 Fe3O4@Au 和 MPSNP 的癌症治疗策略的最新磁学和光学特性。它详细介绍了如何设计 Fe3O4@Au 和 MPSN,使其与药物、受体、配体结合,并破坏肿瘤细胞和靶向给药。这篇综述是一个基础性的综合结构,可指导未来的研究,展望基于Fe3O4@Au和MPSNP的核壳纳米系统用于癌症治疗的前景。
{"title":"Engineering core-shell mesoporous silica and Fe<sub>3</sub>O<sub>4</sub>@Au nanosystems for targeted cancer therapeutics: a review.","authors":"Himani Pathania, Priyanka Chauhan, Vishal Chaudhary, Ajit Khosla, Neetika, Sunil Kumar, Gaurav, Mamta Sharma","doi":"10.1080/02648725.2022.2147685","DOIUrl":"10.1080/02648725.2022.2147685","url":null,"abstract":"<p><p>The extensive utilization of nanoparticles in cancer therapies has inspired a new field of study called cancer nanomedicine. In contrast to traditional anticancer medications, nanomedicines offer a targeted strategy that eliminates side effects and has high efficacy. With its vast surface area, variable pore size, high pore volume, abundant surface chemistry and specific binding affinity, mesoporous silica nanoparticles (MPSNPs) are a potential candidate for cancer diagnosis and treatment. However, there are several bottlenecks associated with nanoparticles, including specific toxicity or affinity towards particular body fluid, which can cater by architecting core-shell nanosystems. The core-shell chemistries, synergistic effects, and interfacial heterojunctions in core-shell nanosystems enhance their stability, catalytic and physicochemical attributes, which possess high performance in cancer therapeutics. This review article summarizes research and development dedicated to engineering mesoporous core-shell nanosystems, especially silica nanoparticles and Fe<sub>3</sub>O<sub>4</sub>@Au nanoparticles, owing to their unique physicochemical characteristics. Moreover, it highlights state-of-the-art magnetic and optical attributes of Fe<sub>3</sub>O<sub>4</sub>@Au and MPSNP-based cancer therapy strategies. It details the designing of Fe<sub>3</sub>O<sub>4</sub>@Au and MPSN to bind with drugs, receptors, ligands, and destroy tumour cells and targeted drug delivery. This review serves as a fundamental comprehensive structure to guide future research towards prospects of core-shell nanosystems based on Fe<sub>3</sub>O<sub>4</sub>@Au and MPSNP for cancer theranostics.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3653-3681"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40709034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in characterization of probiotics and challenges in industrial application. 益生菌表征方面的进展和工业应用中的挑战。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-10-06 DOI: 10.1080/02648725.2022.2122287
Anuj Ranjan, Jayati Arora, Abhishek Chauhan, Rupesh Kumar Basniwal, Arpna Kumari, Vishnu D Rajput, Evgeniya V Prazdnova, Arabinda Ghosh, Nobendu Mukerjee, Saglara S Mandzhieva, Svetlana Sushkova, Tatiana Minkina, Tanu Jindal

An unbalanced diet and poor lifestyle are common reasons for numerous health complications in humans. Probiotics are known to provide substantial benefits to human health by producing several bioactive compounds, vitamins, short-chain fatty acids and short peptides. Diets that contain probiotics are limited to curd, yoghurt, kefir, kimchi, etc. However, exploring the identification of more potential probiotics and enhancing their commercial application to improve the nutritional quality would be a significant step to utilizing the maximum benefits. The complex evolution patterns among the probiotics are the hurdles in their characterization and adequate application in the industries and dairy products. This article has mainly discussed the molecular methods of characterization that are based on the analysis of ribosomal RNA, whole genome, and protein markers and profiles. It also has critically emphasized the emerging challenges in industrial applications of probiotics.

不均衡的饮食和不良的生活方式是导致人类出现多种健康并发症的常见原因。众所周知,益生菌能产生多种生物活性化合物、维生素、短链脂肪酸和短肽,对人体健康大有裨益。含有益生菌的饮食仅限于凝乳、酸奶、酸乳酒、泡菜等。然而,探索发现更多潜在的益生菌并加强其商业应用以提高营养质量,将是利用最大益处的重要一步。益生菌之间复杂的进化模式阻碍了它们的表征和在工业和乳制品中的充分应用。本文主要讨论了基于核糖体 RNA、全基因组、蛋白质标记和图谱分析的分子表征方法。文章还批判性地强调了益生菌在工业应用中面临的新挑战。
{"title":"Advances in characterization of probiotics and challenges in industrial application.","authors":"Anuj Ranjan, Jayati Arora, Abhishek Chauhan, Rupesh Kumar Basniwal, Arpna Kumari, Vishnu D Rajput, Evgeniya V Prazdnova, Arabinda Ghosh, Nobendu Mukerjee, Saglara S Mandzhieva, Svetlana Sushkova, Tatiana Minkina, Tanu Jindal","doi":"10.1080/02648725.2022.2122287","DOIUrl":"10.1080/02648725.2022.2122287","url":null,"abstract":"<p><p>An unbalanced diet and poor lifestyle are common reasons for numerous health complications in humans. Probiotics are known to provide substantial benefits to human health by producing several bioactive compounds, vitamins, short-chain fatty acids and short peptides. Diets that contain probiotics are limited to curd, yoghurt, kefir, kimchi, etc. However, exploring the identification of more potential probiotics and enhancing their commercial application to improve the nutritional quality would be a significant step to utilizing the maximum benefits. The complex evolution patterns among the probiotics are the hurdles in their characterization and adequate application in the industries and dairy products. This article has mainly discussed the molecular methods of characterization that are based on the analysis of ribosomal RNA, whole genome, and protein markers and profiles. It also has critically emphasized the emerging challenges in industrial applications of probiotics.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3226-3269"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33489354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroprotective role of coconut oil for the prevention and treatment of Parkinson's disease: potential mechanisms of action. 椰子油对预防和治疗帕金森病的神经保护作用:潜在的作用机制。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-10-08 DOI: 10.1080/02648725.2022.2122296
Deepika N P, Mohammed Shameer Kondengadan, Sherouk Hussein Sweilam, Md Habibur Rahman, K M Muhasina, Puja Ghosh, Divya Bhargavi, Divya Jyothi Palati, Fathi Maiz, B Duraiswamy

Neurodegenerative disease (ND) is a clinical condition in which neurons degenerate with a consequent loss of functions in the affected brain region. Parkinson's disease (PD) is the second most progressive ND after Alzheimer's disease (AD), which affects the motor system and is characterized by the loss of dopaminergic neurons from the nigrostriatal pathway in the midbrain, leading to bradykinesia, rigidity, resting tremor, postural instability and non-motor symptoms such as cognitive declines, psychiatric disturbances, autonomic failures, sleep difficulties, and pain syndrome. Coconut oil (CO) is an edible oil obtained from the meat of Cocos nucifera fruit that belongs to the palm family and contains 92% saturated fatty acids. CO has been shown to mediate oxidative stress, neuroinflammation, mitochondrial dysfunction, apoptosis and excitotoxicity-induced effects in PD in various in vitro and in vivo models as a multi-target bioagent. CO intake through diet has also been linked to a decreased incidence of PD in people. During digestion, CO is broken down into smaller molecules, like ketone bodies (KBs). The KBs then penetrate the blood-brain barrier (BBB) and are used as a source of energy its ability to cross BBB made this an important class of natural remedies for the treatment of ND. The current review describes the probable neuroprotective potential pathways of CO in PD, either prophylactic or therapeutic. In addition, we briefly addressed the important pathogenic pathways that might be considered to investigate the possible use of CO in neurodegeneration such as AD and PD.

神经退行性疾病(ND)是一种神经元退化并导致受影响脑区功能丧失的临床病症。帕金森病(Parkinson's disease,PD)是仅次于阿尔茨海默病(Alzheimer's disease,AD)的第二大进展性神经退行性疾病,影响运动系统,其特征是中脑黑质通路多巴胺能神经元的丧失,导致运动迟缓、僵直、静止性震颤、姿势不稳和非运动症状,如认知能力下降、精神障碍、自主神经功能衰竭、睡眠困难和疼痛综合征。椰子油(CO)是一种食用油,取自棕榈科植物椰子的果肉,含有 92% 的饱和脂肪酸。在各种体外和体内模型中,椰子油作为一种多靶点生物制剂,已被证明可介导氧化应激、神经炎症、线粒体功能障碍、细胞凋亡和兴奋性毒性诱导的帕金森病效应。通过饮食摄入一氧化碳也与帕金森病发病率的降低有关。在消化过程中,一氧化碳会被分解成更小的分子,如酮体(KBs)。然后,KBs 穿透血脑屏障(BBB),用作能量来源,其穿过 BBB 的能力使其成为治疗 ND 的一类重要天然疗法。本综述介绍了 CO 在预防或治疗帕金森病方面的潜在神经保护途径。此外,我们还简要论述了重要的致病途径,这些途径可用于研究一氧化碳在神经变性(如注意力缺失症和帕金森病)中的可能用途。
{"title":"Neuroprotective role of coconut oil for the prevention and treatment of Parkinson's disease: potential mechanisms of action.","authors":"Deepika N P, Mohammed Shameer Kondengadan, Sherouk Hussein Sweilam, Md Habibur Rahman, K M Muhasina, Puja Ghosh, Divya Bhargavi, Divya Jyothi Palati, Fathi Maiz, B Duraiswamy","doi":"10.1080/02648725.2022.2122296","DOIUrl":"10.1080/02648725.2022.2122296","url":null,"abstract":"<p><p>Neurodegenerative disease (ND) is a clinical condition in which neurons degenerate with a consequent loss of functions in the affected brain region. Parkinson's disease (PD) is the second most progressive ND after Alzheimer's disease (AD), which affects the motor system and is characterized by the loss of dopaminergic neurons from the nigrostriatal pathway in the midbrain, leading to bradykinesia, rigidity, resting tremor, postural instability and non-motor symptoms such as cognitive declines, psychiatric disturbances, autonomic failures, sleep difficulties, and pain syndrome. Coconut oil (CO) is an edible oil obtained from the meat of <i>Cocos nucifera</i> fruit that belongs to the palm family and contains 92% saturated fatty acids. CO has been shown to mediate oxidative stress, neuroinflammation, mitochondrial dysfunction, apoptosis and excitotoxicity-induced effects in PD in various <i>in vitro</i> and <i>in vivo</i> models as a multi-target bioagent. CO intake through diet has also been linked to a decreased incidence of PD in people. During digestion, CO is broken down into smaller molecules, like ketone bodies (KBs). The KBs then penetrate the blood-brain barrier (BBB) and are used as a source of energy its ability to cross BBB made this an important class of natural remedies for the treatment of ND. The current review describes the probable neuroprotective potential pathways of CO in PD, either prophylactic or therapeutic. In addition, we briefly addressed the important pathogenic pathways that might be considered to investigate the possible use of CO in neurodegeneration such as AD and PD.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3346-3378"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33494809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of retraction. 撤回声明。
IF 6 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-07-01 DOI: 10.1080/10717544.2022.2088154
{"title":"Statement of retraction.","authors":"","doi":"10.1080/10717544.2022.2088154","DOIUrl":"10.1080/10717544.2022.2088154","url":null,"abstract":"","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"1"},"PeriodicalIF":6.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11104688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40553789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biogenic biocompatible silver nanoparticles: a promising antibacterial agent. 生物源生物相容性银纳米粒子:一种前景广阔的抗菌剂。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-08-02 DOI: 10.1080/02648725.2022.2106084
Sandip Kumar Chandraker, Ravindra Kumar

The biogenic synthesis of silver nanoparticles (AgNPs) are gaining attention because they are eco-friendly, non-hazardous, economical and devoid of the drawbacks of physicochemical processes. Biogenic approaches for synthesizing nanoparticles (NPs) using plant leaves, seeds, bark, stems, fruits, roots and flowers are highly cost-effective compared to other methods. Silver (Ag) has been used since ancient times, but biogenic AgNPs have only been made in the last few decades. They have been employed primarily in the food and pharmaceutical industries as antimicrobials and antioxidants. Recent studies have confirmed that many molecules present in different bacteria, including Escherichia coli, Staphylococcus aureus, Citrobacter koseri, Bacillus cereus, Salmonella typhi, Klebsipneumoniaoniae, Vibrio parahaemolyticus, Pseudomonas Aeruginosa, are bound to the AgNPs and can be inhibited using multifaceted mechanisms like AgNPs inter inside the cells, free radicals, ROS generation and modulate transduction pathways. Recent breakthroughs in nanobiotechnology-based therapeutics have opened up new possibilities for fighting microorganisms. Thus, in particular, biogenic AgNPs as powerful antibacterial agents have gained much interest. Surface charge, colloidal state, shape, concentration and size are the most critical physicochemical characteristics that determine the antibacterial potential of AgNPs. Based on this review, it can be stated that AgNPs could be made better in terms of their potency, durability, accuracy, biosecurity and compatibility.

银纳米粒子(AgNPs)的生物合成方法因其环保、无害、经济、无物理化学过程的弊端而备受关注。与其他方法相比,利用植物叶、种子、树皮、茎、果实、根和花合成纳米粒子(NPs)的生物方法具有很高的成本效益。银(Ag)自古以来就有使用,但生物银纳米粒子(AgNPs)只是在过去几十年才被制造出来。它们主要用于食品和制药行业,作为抗菌剂和抗氧化剂。最近的研究证实,不同细菌(包括大肠杆菌、金黄色葡萄球菌、柯氏柠檬杆菌、蜡样芽孢杆菌、伤寒沙门氏菌、克雷伯肺炎球菌、副溶血性弧菌、绿脓杆菌)中存在的许多分子都与 AgNPs 结合在一起,并可通过 AgNPs 在细胞内的相互作用、自由基、ROS 生成和调节转导途径等多方面机制来抑制这些分子。基于纳米生物技术的疗法最近取得了突破性进展,为抗击微生物开辟了新的可能性。因此,作为强效抗菌剂的生物源 AgNPs 尤其受到了广泛关注。表面电荷、胶体状态、形状、浓度和尺寸是决定 AgNPs 抗菌潜力的最关键的物理化学特征。综上所述,AgNPs 在效力、耐久性、准确性、生物安全性和兼容性等方面都可以做得更好。
{"title":"Biogenic biocompatible silver nanoparticles: a promising antibacterial agent.","authors":"Sandip Kumar Chandraker, Ravindra Kumar","doi":"10.1080/02648725.2022.2106084","DOIUrl":"10.1080/02648725.2022.2106084","url":null,"abstract":"<p><p>The biogenic synthesis of silver nanoparticles (AgNPs) are gaining attention because they are eco-friendly, non-hazardous, economical and devoid of the drawbacks of physicochemical processes. Biogenic approaches for synthesizing nanoparticles (NPs) using plant leaves, seeds, bark, stems, fruits, roots and flowers are highly cost-effective compared to other methods. Silver (Ag) has been used since ancient times, but biogenic AgNPs have only been made in the last few decades. They have been employed primarily in the food and pharmaceutical industries as antimicrobials and antioxidants. Recent studies have confirmed that many molecules present in different bacteria, including <i>Escherichia coli</i>, <i>Staphylococcus aureus</i>, <i>Citrobacter koseri</i>, <i>Bacillus cereus</i>, <i>Salmonella typhi</i>, <i>Klebsipneumoniaoniae</i>, <i>Vibrio parahaemolyticus</i>, <i>Pseudomonas Aeruginosa</i>, are bound to the AgNPs and can be inhibited using multifaceted mechanisms like AgNPs inter inside the cells, free radicals, ROS generation and modulate transduction pathways. Recent breakthroughs in nanobiotechnology-based therapeutics have opened up new possibilities for fighting microorganisms. Thus, in particular, biogenic AgNPs as powerful antibacterial agents have gained much interest. Surface charge, colloidal state, shape, concentration and size are the most critical physicochemical characteristics that determine the antibacterial potential of AgNPs. Based on this review, it can be stated that AgNPs could be made better in terms of their potency, durability, accuracy, biosecurity and compatibility.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3113-3147"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40663232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive review on removal of pollutants from wastewater through microbial nanobiotechnology -based solutions. 通过基于微生物纳米生物技术的解决方案去除废水中污染物的综合综述。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-08-03 DOI: 10.1080/02648725.2022.2106014
Shristi Kishore, Sumira Malik, Maulin P Shah, Jutishna Bora, Vishal Chaudhary, Lamha Kumar, Riyaz Z Sayyed, Anuj Ranjan

Increasing wastewater pollution owing to the briskly rising human population, rapid industrialization, and fast urbanization has necessitated highly efficient wastewater treatment technologies. Although several methods of wastewater treatments are in practice, expensiveness, use of noxious chemicals, generation of unsafe by-products, and longer time consumption restrain their use to a great extent. Over the last few decades, nanotechnological wastewater treatment approaches have received widespread recognition globally. Microbially fabricated nanoparticles reduce the utilization of reducing, capping, and stabilizing agents, and exhibit higher adsorptive and catalytic efficiency than chemically synthesized nanomaterials. The present review comprehensively summarizes the applications of microbial nanotechnology in the removal of a wide range of noxious wastewater pollutants. Moreover, prospects and challenges associated with the integration of nanotechnology with other biological treatment technologies including algal-membrane bioreactor, aerobic digestion, microbial fuel cells, and microbial nanofiber webs have also been briefly discussed.

由于人口急剧增加、工业化进程加快和城市化进程加快,废水污染日益严重,因此需要高效的废水处理技术。虽然目前有多种废水处理方法,但昂贵的费用、有毒化学品的使用、不安全副产品的产生以及较长的耗时在很大程度上限制了这些方法的使用。在过去的几十年里,纳米技术废水处理方法在全球范围内得到了广泛认可。与化学合成的纳米材料相比,微生物制造的纳米颗粒可减少还原剂、封盖剂和稳定剂的使用,并表现出更高的吸附和催化效率。本综述全面总结了微生物纳米技术在去除各种有毒废水污染物方面的应用。此外,还简要讨论了纳米技术与其他生物处理技术(包括藻膜生物反应器、好氧消化、微生物燃料电池和微生物纳米纤维网)相结合的前景和挑战。
{"title":"A comprehensive review on removal of pollutants from wastewater through microbial nanobiotechnology -based solutions.","authors":"Shristi Kishore, Sumira Malik, Maulin P Shah, Jutishna Bora, Vishal Chaudhary, Lamha Kumar, Riyaz Z Sayyed, Anuj Ranjan","doi":"10.1080/02648725.2022.2106014","DOIUrl":"10.1080/02648725.2022.2106014","url":null,"abstract":"<p><p>Increasing wastewater pollution owing to the briskly rising human population, rapid industrialization, and fast urbanization has necessitated highly efficient wastewater treatment technologies. Although several methods of wastewater treatments are in practice, expensiveness, use of noxious chemicals, generation of unsafe by-products, and longer time consumption restrain their use to a great extent. Over the last few decades, nanotechnological wastewater treatment approaches have received widespread recognition globally. Microbially fabricated nanoparticles reduce the utilization of reducing, capping, and stabilizing agents, and exhibit higher adsorptive and catalytic efficiency than chemically synthesized nanomaterials. The present review comprehensively summarizes the applications of microbial nanotechnology in the removal of a wide range of noxious wastewater pollutants. Moreover, prospects and challenges associated with the integration of nanotechnology with other biological treatment technologies including algal-membrane bioreactor, aerobic digestion, microbial fuel cells, and microbial nanofiber webs have also been briefly discussed.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3087-3112"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40582078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An insight into the placental growth factor (PlGf)/angii axis in Covid-19: a detrimental intersection. 洞察 Covid-19 中的胎盘生长因子(PlGf)/angii 轴:有害的交叉点。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-09-12 DOI: 10.1080/02648725.2022.2122291
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Thabat J Al-Maiahy, Athanasios Alexiou, Nobendu Mukerjee, Gaber El-Saber Batiha

Coronavirus disease 2019 (Covid-19) is a recent and current infectious pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Covid-19 may lead to the development of acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and extrapulmonary manifestations in severe cases. Down-regulation of angiotensin-converting enzyme (ACE2) by the SARS-CoV-2 increases the production of angiotensin II (AngII), which increases the release of pro-inflammatory cytokines and placental growth factor (PlGF). PlGF is a critical molecule involved in vasculogenesis and angiogenesis. PlGF is stimulated by AngII in different inflammatory diseases through a variety of signaling pathways. PlGF and AngII are interacted in SARS-CoV-2 infection resulting in the production of pro-inflammatory cytokines and the development of Covid-19 complications. Both AngII and PlGF are interacted and are involved in the progression of inflammatory disorders; therefore, we aimed in this review to highlight the potential role of the PlGF/AngII axis in Covid-19.

冠状病毒病 2019(Covid-19)是由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起的近期和当前的传染性流行病。Covid-19可能导致急性肺损伤(ALI)、急性呼吸窘迫综合征(ARDS)的发生,严重病例还可能出现肺外表现。SARS-CoV-2 对血管紧张素转换酶(ACE2)的下调增加了血管紧张素 II(AngII)的产生,从而增加了促炎细胞因子和胎盘生长因子(PlGF)的释放。PlGF 是参与血管生成和血管生成的重要分子。在不同的炎症性疾病中,AngII 会通过多种信号通路刺激 PlGF。在 SARS-CoV-2 感染中,PlGF 和 AngII 相互作用,导致促炎细胞因子的产生和 Covid-19 并发症的发生。AngII 和 PlGF 相互作用并参与炎症性疾病的进展;因此,我们在本综述中旨在强调 PlGF/AngII 轴在 Covid-19 中的潜在作用。
{"title":"An insight into the placental growth factor (PlGf)/angii axis in Covid-19: a detrimental intersection.","authors":"Hayder M Al-Kuraishy, Ali I Al-Gareeb, Thabat J Al-Maiahy, Athanasios Alexiou, Nobendu Mukerjee, Gaber El-Saber Batiha","doi":"10.1080/02648725.2022.2122291","DOIUrl":"10.1080/02648725.2022.2122291","url":null,"abstract":"<p><p>Coronavirus disease 2019 (Covid-19) is a recent and current infectious pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Covid-19 may lead to the development of acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and extrapulmonary manifestations in severe cases. Down-regulation of angiotensin-converting enzyme (ACE2) by the SARS-CoV-2 increases the production of angiotensin II (AngII), which increases the release of pro-inflammatory cytokines and placental growth factor (PlGF). PlGF is a critical molecule involved in vasculogenesis and angiogenesis. PlGF is stimulated by AngII in different inflammatory diseases through a variety of signaling pathways. PlGF and AngII are interacted in SARS-CoV-2 infection resulting in the production of pro-inflammatory cytokines and the development of Covid-19 complications. Both AngII and PlGF are interacted and are involved in the progression of inflammatory disorders; therefore, we aimed in this review to highlight the potential role of the PlGF/AngII axis in Covid-19.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3326-3345"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33463253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapeutic strategies to induce inflection in the immune response: therapy for cancer and COVID-19. 诱导免疫反应拐点的免疫治疗策略:癌症疗法和 COVID-19。
IF 6.5 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY Pub Date : 2024-12-01 Epub Date: 2022-11-21 DOI: 10.1080/02648725.2022.2147661
Saba Hasan, Prankur Awasthi, Sumira Malik, Manish Dwivedi

Cancer has agonized the human race for millions of years. The present decade witnesses biological therapeutics to combat cancer effectively. Cancer Immunotherapy involves the use of therapeutics for manipulation of the immune system by immune agents like cytokines, vaccines, and transfection agents. Recently, this therapeutic approach has got vast attention due to the current pandemic COVID-19 and has been very effective. Concerning cancer, immunotherapy is based on the activation of the host's antitumor response by enhancing effector cell number and the production of soluble mediators, thereby reducing the host's suppressor mechanisms by induction of a tumour killing environment and by modulating immune checkpoints. In the present era, immunotherapies have gained traction and momentum as a pedestal of cancer treatment, improving the prognosis of many patients with a wide variety of haematological and solid malignancies. Food supplements, natural immunomodulatory drugs, and phytochemicals, with recent developments, have shown positive trends in cancer treatment by improving the immune system. The current review presents the systematic studies on major immunotherapeutics and their development for the effective treatment of cancers as well as in COVID-19. The focus of the review is to highlight comparative analytics of existing and novel immunotherapies in cancers, concerning immunomodulatory drugs and natural immunosuppressants, including immunotherapy in COVID-19 patients.

数百万年来,癌症一直困扰着人类。当今的十年见证了有效抗击癌症的生物疗法。癌症免疫疗法包括利用细胞因子、疫苗和转染剂等免疫制剂操纵免疫系统的疗法。最近,这种治疗方法因目前流行的 COVID-19 而受到广泛关注,并且非常有效。关于癌症,免疫疗法的基础是通过增强效应细胞数量和产生可溶性介质来激活宿主的抗肿瘤反应,从而通过诱导肿瘤杀伤环境和调节免疫检查点来减少宿主的抑制机制。在当今时代,免疫疗法作为癌症治疗的基石,已经获得了越来越多的关注和动力,改善了许多血液和实体恶性肿瘤患者的预后。近年来,食品补充剂、天然免疫调节药物和植物化学物质通过改善免疫系统,在癌症治疗中呈现出积极的发展趋势。本综述介绍了主要免疫治疗药物的系统研究及其在有效治疗癌症和 COVID-19 中的发展情况。综述的重点是突出现有和新型癌症免疫疗法的比较分析,涉及免疫调节药物和天然免疫抑制剂,包括 COVID-19 患者的免疫疗法。
{"title":"Immunotherapeutic strategies to induce inflection in the immune response: therapy for cancer and COVID-19.","authors":"Saba Hasan, Prankur Awasthi, Sumira Malik, Manish Dwivedi","doi":"10.1080/02648725.2022.2147661","DOIUrl":"10.1080/02648725.2022.2147661","url":null,"abstract":"<p><p>Cancer has agonized the human race for millions of years. The present decade witnesses biological therapeutics to combat cancer effectively. Cancer Immunotherapy involves the use of therapeutics for manipulation of the immune system by immune agents like cytokines, vaccines, and transfection agents. Recently, this therapeutic approach has got vast attention due to the current pandemic COVID-19 and has been very effective. Concerning cancer, immunotherapy is based on the activation of the host's antitumor response by enhancing effector cell number and the production of soluble mediators, thereby reducing the host's suppressor mechanisms by induction of a tumour killing environment and by modulating immune checkpoints. In the present era, immunotherapies have gained traction and momentum as a pedestal of cancer treatment, improving the prognosis of many patients with a wide variety of haematological and solid malignancies. Food supplements, natural immunomodulatory drugs, and phytochemicals, with recent developments, have shown positive trends in cancer treatment by improving the immune system. The current review presents the systematic studies on major immunotherapeutics and their development for the effective treatment of cancers as well as in COVID-19. The focus of the review is to highlight comparative analytics of existing and novel immunotherapies in cancers, concerning immunomodulatory drugs and natural immunosuppressants, including immunotherapy in COVID-19 patients.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":" ","pages":"3571-3610"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40701198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ACS Applied Nano Materials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1